Management of Wheezing Not Responding to Nebulizer Treatment

Assessment and Initial Management

When wheezing does not respond to initial nebulizer treatment, add ipratropium bromide (500 μg) to the beta-agonist and repeat the nebulization, as recommended by the British Thoracic Society 1, 2
Evaluate for life-threatening features: poor lung function, silent chest, cyanosis, feeble respiratory effort, bradycardia, hypotension, exhaustion, confusion, or coma, according to the British Thoracic Society guidelines 3, 2
Check vital signs: respiratory rate ≥25/min, heart rate ≥110/min, and poor lung function indicate severe asthma, as defined by the British Thoracic Society 4
Assess ability to complete sentences in one breath - inability suggests severe airflow obstruction, as noted by the British Thoracic Society 5

Ensure oxygen is used as the driving gas whenever possible, except in patients with carbon dioxide retention and acidosis, as recommended by the British Thoracic Society 2
Consider additional pharmacological interventions, including oral corticosteroids and intravenous bronchodilators, as suggested by the British Thoracic Society 5, 6, 1, 4
Assess need for hospital admission, based on guidelines from the British Thoracic Society 5
Consider assisted ventilation for persistent wheezing despite other measures, as recommended by the British Thoracic Society 1, 4
Continue nebulized treatments at 4-6 hourly intervals until lung function improves, as suggested by the British Thoracic Society 4
Measure arterial blood gases if patient requires hospital admission, as recommended by the British Thoracic Society 2

In patients with carbon dioxide retention and acidosis, use air (not oxygen) to drive the nebulizer, as recommended by the British Thoracic Society 2
For severe exacerbations, consider combination therapy with beta-agonist and ipratropium bromide 4-6 hourly, as suggested by the British Thoracic Society 2

Monitor peak flow measurements before and after treatments, as recommended by the British Thoracic Society 7
Continue nebulized treatments until lung function improves and diurnal variability decreases, as suggested by the British Thoracic Society 4
Before discharge, transition to hand-held inhaler therapy for at least 24 hours to ensure stability, as recommended by the British Thoracic Society 2, 4